Moderna | MRNA - Current Assets


Moderna reported $7.34B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.27B 43.88M Sep/2026
Agios Pharmaceuticals USD 752.1M 34.43M Sep/2026
Alnylam Pharmaceuticals USD 5.11B 492.49M Sep/2026
Amgen USD 34.36B 598M Sep/2026
Arrowhead Research USD 1.29B 382.19M Sep/2026
Biogen USD 7.58B 278.7M Sep/2026
BioMarin Pharmaceutical USD 3.92B 50.99M Sep/2026
Celltrion KRW 493.66B 12.09B Jun/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Divis Laboratories Ltd INR 124.39B 13.43B Sep/2026
Gilead Sciences USD 16.55B 4.02B Sep/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Incyte USD 5.52B 505.2M Sep/2026
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
Kangmei Pharma CNY 6.66B 143.43M Jun/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Moderna USD 7.34B 1.53B Sep/2026
Organigram Holdings CAD 280.09M 30M Jun/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pharma Mar EUR 295.56M 14.62M Sep/2026
Puma Biotechnology USD 143.58M 7M Sep/2025
Qiagen NV USD 1.66B 116.37M Jun/2026
Regeneron Pharmaceuticals USD 20.8B 2.35B Sep/2026
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sarepta Therapeutics USD 2.27B 49.06M Sep/2026
Sartorius EUR 1.65B 8.4M Sep/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tilray USD 729.32M 28.18M Sep/2025
Ultragenyx Pharmaceutical USD 544M 62M Sep/2026
United Therapeutics USD 2.88B 603.5M Sep/2026
Vertex Pharmaceuticals USD 11.69B 857.4M Sep/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 13.48B 2.32B Sep/2026